FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001231501> ?p ?o ?g. }

• W2001231501 endingPage "270" @default.
• W2001231501 startingPage "265" @default.
• W2001231501 abstract "Anophthalmia and microphthalmia (A/M) are early-eye-development anomalies resulting in absent or small ocular globes, respectively. A/M anomalies occur in syndromic or nonsyndromic forms. They are genetically heterogeneous, some mutations in some genes being responsible for both anophthalmia and microphthalmia. Using a combination of homozygosity mapping, exome sequencing, and Sanger sequencing, we identified homozygosity for one splice-site and two missense mutations in the gene encoding the A3 isoform of the aldehyde dehydrogenase 1 (ALDH1A3) in three consanguineous families segregating A/M with occasional orbital cystic, neurological, and cardiac anomalies. ALDH1A3 is a key enzyme in the formation of a retinoic acid gradient along the dorso-ventral axis during early eye development. Transitory expression of mutant ALDH1A3 open reading frames showed that both missense mutations reduce the accumulation of the enzyme, potentially leading to altered retinoic acid synthesis. Although the role of retinoic acid signaling in eye development is well established, our findings provide genetic evidence of a direct link between retinoic-acid-synthesis dysfunction and early-eye-development anomalies in humans. Anophthalmia and microphthalmia (A/M) are early-eye-development anomalies resulting in absent or small ocular globes, respectively. A/M anomalies occur in syndromic or nonsyndromic forms. They are genetically heterogeneous, some mutations in some genes being responsible for both anophthalmia and microphthalmia. Using a combination of homozygosity mapping, exome sequencing, and Sanger sequencing, we identified homozygosity for one splice-site and two missense mutations in the gene encoding the A3 isoform of the aldehyde dehydrogenase 1 (ALDH1A3) in three consanguineous families segregating A/M with occasional orbital cystic, neurological, and cardiac anomalies. ALDH1A3 is a key enzyme in the formation of a retinoic acid gradient along the dorso-ventral axis during early eye development. Transitory expression of mutant ALDH1A3 open reading frames showed that both missense mutations reduce the accumulation of the enzyme, potentially leading to altered retinoic acid synthesis. Although the role of retinoic acid signaling in eye development is well established, our findings provide genetic evidence of a direct link between retinoic-acid-synthesis dysfunction and early-eye-development anomalies in humans. Anophthalmia and microphthalmia (A/M) are rare errors of eye development (with a combined prevalence of 3:100,000 to 30:100,000).1Verma A.S. Fitzpatrick D.R. Anophthalmia and microphthalmia.Orphanet J. Rare Dis. 2007; 2: 47Crossref PubMed Scopus (252) Google Scholar Whereas true anophthalmia refers to the histological absence of ocular tissue in the orbit, microphthalmia ranges from extreme cases with only tiny or no visible remnants of globe in the orbit (also called “clinical anophthalmia”) to simple microphthalmia with structurally normal small eyes (axial length at least 2 SD below the mean for an individual of that age).1Verma A.S. Fitzpatrick D.R. Anophthalmia and microphthalmia.Orphanet J. Rare Dis. 2007; 2: 47Crossref PubMed Scopus (252) Google Scholar A/M may affect one or both eyes. Both errors are associated with systemic anomalies in at least 50% of individuals,2Tucker S. Jones B. Collin R. Systemic anomalies in 77 patients with congenital anophthalmos or microphthalmos.Eye (Lond.). 1996; 10: 310-314Crossref PubMed Scopus (41) Google Scholar a large proportion of such individuals presenting with defined syndromes.1Verma A.S. Fitzpatrick D.R. Anophthalmia and microphthalmia.Orphanet J. Rare Dis. 2007; 2: 47Crossref PubMed Scopus (252) Google Scholar, 3Bardakjian T.M. Schneider A. The genetics of anophthalmia and microphthalmia.Curr. Opin. Ophthalmol. 2011; 22: 309-313Crossref PubMed Scopus (50) Google Scholar, 4Slavotinek A.M. Eye development genes and known syndromes.Mol. Genet. Metab. 2011; 104: 448-456Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 5Shaham O. Menuchin Y. Farhy C. Ashery-Padan R. Pax6: a multi-level regulator of ocular development.Prog. Retin. Eye Res. 2012; 31: 351-376Crossref PubMed Scopus (148) Google Scholar Learning difficulties are described in one-fifth of individuals with A/M and/or coloboma.6Morrison D. FitzPatrick D. Hanson I. Williamson K. van Heyningen V. Fleck B. Jones I. Chalmers J. Campbell H. National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology.J. Med. Genet. 2002; 39: 16-22Crossref PubMed Scopus (188) Google Scholar This frequency is probably higher in individuals with A/M when isolated colobomia cases are excluded. Both genetic and environmental factors contribute to A/M. Monogenic A/M is inherited as autosomal-dominant (AD), autosomal-recessive (AR), or X-linked traits. Both AD and AR forms are characterized by clinical and genetic heterogeneity.3Bardakjian T.M. Schneider A. The genetics of anophthalmia and microphthalmia.Curr. Opin. Ophthalmol. 2011; 22: 309-313Crossref PubMed Scopus (50) Google Scholar To date, mutations in genes critical for normal eye development have been identified in 20%–40% of A/M cases, some genes being involved in simple, complex, and syndromic A/M.7Williamson K.A. Hever A.M. Rainger J. Rogers R.C. Magee A. Fiedler Z. Keng W.T. Sharkey F.H. McGill N. Hill C.J. et al.Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.Hum. Mol. Genet. 2006; 15: 1413-1422Crossref PubMed Scopus (169) Google Scholar, 8Chassaing N. Golzio C. Odent S. Lequeux L. Vigouroux A. Martinovic-Bouriel J. Tiziano F.D. Masini L. Piro F. Maragliano G. et al.Phenotypic spectrum of STRA6 mutations: from Matthew-Wood syndrome to non-lethal anophthalmia.Hum. Mutat. 2009; 30: E673-E681Crossref PubMed Scopus (76) Google Scholar, 9Chassaing N. Ragge N. Kariminejad A. Buffet A. Ghaderi-Sohi S. Martinovic J. Calvas P. Mutation analysis of the STRA6 gene in isolated and non-isolated anophthalmia/microphthalmia.Clin. Genet. 2012; 9999PubMed Google Scholar, 10Ragge N.K. Brown A.G. Poloschek C.M. Lorenz B. Henderson R.A. Clarke M.P. Russell-Eggitt I. Fielder A. Gerrelli D. Martinez-Barbera J.P. et al.Heterozygous mutations of OTX2 cause severe ocular malformations.Am. J. Hum. Genet. 2005; 76: 1008-1022Abstract Full Text Full Text PDF PubMed Scopus (250) Google Scholar With the exception of SOX2 mutations, which underlie 10%–15% of severe A/M cases, mutations in other genes are, individually, uncommon causes of the disease.3Bardakjian T.M. Schneider A. The genetics of anophthalmia and microphthalmia.Curr. Opin. Ophthalmol. 2011; 22: 309-313Crossref PubMed Scopus (50) Google Scholar, 10Ragge N.K. Brown A.G. Poloschek C.M. Lorenz B. Henderson R.A. Clarke M.P. Russell-Eggitt I. Fielder A. Gerrelli D. Martinez-Barbera J.P. et al.Heterozygous mutations of OTX2 cause severe ocular malformations.Am. J. Hum. Genet. 2005; 76: 1008-1022Abstract Full Text Full Text PDF PubMed Scopus (250) Google Scholar, 11Ragge N.K. Lorenz B. Schneider A. Bushby K. de Sanctis L. de Sanctis U. Salt A. Collin J.R. Vivian A.J. Free S.L. et al.SOX2 anophthalmia syndrome.Am. J. Med. Genet. A. 2005; 135 (discussion 8): 1-7Crossref PubMed Scopus (181) Google Scholar, 12Bakrania P. Robinson D.O. Bunyan D.J. Salt A. Martin A. Crolla J.A. Wyatt A. Fielder A. Ainsworth J. Moore A. et al.SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.Br. J. Ophthalmol. 2007; 91: 1471-1476Crossref PubMed Scopus (88) Google Scholar Using a combination of the Affymetrix GeneChip Human Mapping 10K 2.0 Array and microsatellite markers, we performed homozygosity mapping in a multiplex inbred Pakistani pedigree with multiple loops of consanguinity (Figure 1) in whom Sanger sequencing failed to detect mutations in GDF6 (MIM 601147), FOXE3 (MIM 601094), OTX2 (IM 600037), PAX6 (MIM 607108), RAX (MIM 601881), SOX2 (MIM 184429), and VSX2 (CHX10, [MIM 142993]). Informed consent was obtained from each individual participating in this study, which was approved by Le Comité de Protection des Personnes Ile de France II or by the Cambridgeshire 1 Multicenter Research Ethics Committee (04/Q0104/129). Considering that A/M-causing mutations are rare, we assumed that affected individuals of the two available nuclear families (IV1, IV4, and IV5; Figure 1) were most likely homozygous for the same disease-causing mutation and surrounding SNP markers. This strategy defined three regions with LOD scores ≥ 3 (2p24.2–p24.1, 5.5Mb; 8q24, 0.7Mb; and 15q26.3, 3.8Mb) and one region with a LOD score close to 3 (4p14–p11, 10.1Mb) (Figure 1A). Analysis of highly informative microsatellite markers in each candidate region allowed us to show that an apparent linkage on chromosomes 2p24, 8q24, and 4p14–p11 resulted from uninformative SNP markers (data not shown). Conversely, homozygosity for informative markers of the 15q26.3 locus was confirmed (Figure 1B). The critical interval on 15q26.3 spanned 3.8 Mb and contained 31 genes. To identify the disease-causing mutation, we subjected the DNA of the index case, IV1, to whole-exome sequencing by using the SureSelectXT Human All Exon V3 50 Mb target-enrichment kit (Agilent Technologies, Massy, France) in accordance with the manufacturer’s recommendations. Each genomic DNA fragment was sequenced with the use of the paired-end strategy and an average read length of 75 bases (Illumina HISEQ, Illumina, San Diego, CA, USA). Image analysis and base calling were performed with the Illumina Sequence Control Software (SCS) with Real Time Analysis (RTA) version 1.9 and default parameters were used. Sequences were aligned to the human genome reference sequence (hg19 assembly), and SNPs were called on the basis of allele calls and read depth with the use of the CASAVA pipeline (Consensus Assessment of Sequence and Variation 1.8, Illumina). Genetic variation annotation was performed with an in-house pipeline (Plateforme Bioinformatique Paris Descartes, Paris, France). Considering that A/M-causing mutations are uncommon, we searched for homozygous variants absent in the dbSNP132, Exome Variant Server, 1000 Genomes, and in-house databases or with allelic frequencies <0.01. We found no homozygosity for consensus splice-site changes, nonsense mutations, or insertions or deletions in coding regions upon whole-genome analysis. We subsequently selected nonsynonymous changes predicted to be “damaging” or “possibly damaging” using the Polyphen and SIFT programs available through our in-house analysis pipeline. This led to the selection of 28 variants in 27 genes. The only gene mapping in the 3.8 Mb interval on chromosome 15q26.3, ALDH1A3 (NM_000693.2 [MIM600463]), harbored a homozygote missense mutation, c.265C>T (p.Arg89Cys) (Table S1, available online). The mutation was confirmed by Sanger sequencing, and familial analysis confirmed the biparental transmission of the mutation and segregation with the disease (Figure 1). ALDH1A3 encodes a retinaldehyde dehydrogenase (ALDH1A3; also referred to as RALDH1A3, RALDH3, or ADLH6) involved in retinoic acid synthesis through the oxidation of retinaldehyde. It plays a pivotal role in retinoic acid signaling in eye development.13Grün F. Hirose Y. Kawauchi S. Ogura T. Umesono K. Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development.J. Biol. Chem. 2000; 275: 41210-41218Crossref PubMed Scopus (110) Google Scholar, 14Graham C.E. Brocklehurst K. Pickersgill R.W. Warren M.J. Characterization of retinaldehyde dehydrogenase 3.Biochem. J. 2006; 394: 67-75Crossref PubMed Scopus (37) Google Scholar, 15Cvekl A. Wang W.L. Retinoic acid signaling in mammalian eye development.Exp. Eye Res. 2009; 89: 280-291Crossref PubMed Scopus (122) Google Scholar, 16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 17Fuhrmann S. Eye morphogenesis and patterning of the optic vesicle.Curr. Top. Dev. Biol. 2010; 93: 61-84Crossref PubMed Scopus (249) Google Scholar Thus, ALDH1A3 was regarded a strong candidate gene by virtue of both its localization and its function. We performed Sanger sequencing of all 13 exons and the intron-exon boundaries of ALDH1A3 (Table S2) in a series of 28 additional A/M index individuals born to consanguineous parents with no mutation in GDF6, FOXE3, OTX2, PAX6, RAX, SOX2, or VSX2. We identified homozygous ALDH1A3 mutations in 2 of 28 simplex individuals (Figure 1). The first simplex individual, a girl born to Turkish parents, harbored a homozygous missense mutation, c.1477G>C (p.Ala493Pro) (IV1, family 2). The second individual, a girl born to Moroccan parents, harbored a homozygous splice-site mutation, c.475+1G>T (II3, family 3). Biparental transmission was confirmed in the two families. The three mutations were absent in the SNP databases, in the Exome Variant Server, and in 200 control chromosomes. The mutations were analyzed with Alamut Mutation Interpretation software, a decision-support system for mutation interpretation based on Align DGVD, Polyphen-2, SIFT, SpliceSiteFinder-like, MaxEntScan, NNSPLICE, and Human Splicing Finder. The c.475+1G>T mutation is predicted to abolish the splice-donor site of intron 4. This is expected to result in an in-frame skipping of exon 5, which contributes to the nicotinamide adenine dinucleotide (NAD) binding pocket (exon 5 codes for residues 159–179; NAD binding pocket: residues 8–135 and 159–170; Protein Data Bank [PDB] 1BXS). The c.265C>T (p.Arg89Cys) mutation affects an amino acid conserved from human to worm and in the ALDH1A1 and ALDH1A2 paralogs. The c.1477G>C (p.Ala493Pro) mutation changes a residue conserved from human to frog. In fish, fly, and C. elegans, the p.Ala493 residue is replaced by a leucine or a glycine residue. The replacement of the positively charged p.Arg89 by a cysteine residue and the replacement of p.Ala495 by a proline residue were both predicted to be deleterious by the Alamut Interpretation software. The three-dimensional structure of the tetrameric human ALDH1A3 (residues 20–511; Figure S1A) was modeled by comparative protein modeling methods and energy minimization with the use of the Swiss-Model program in the automated mode.18Arnold K. Bordoli L. Kopp J. Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.Bioinformatics. 2006; 22: 195-201Crossref PubMed Scopus (6024) Google Scholar, 19Kiefer F. Arnold K. Künzli M. Bordoli L. Schwede T. The SWISS-MODEL Repository and associated resources.Nucleic Acids Res. 2009; 37: D387-D392Crossref PubMed Scopus (1613) Google Scholar, 20Peitsch M.C. Protein modeling by E-mail.Nature Biotechnology. 1995; 13: 658-660Crossref Scopus (115) Google Scholar The 2.35 Å coordinate set for the tetrameric sheep liver class 1 aldehyde dehydrogenase with bound NAD (PDB code 1BXS) was used as a template for modeling the human ALDH1A3 protein (71.3% sequence identity). Swiss-PdbViewer 3.7 was used for structural insight into ALDH1A3 substitutions. The p.Arg89 residue is located between two helixes in a conserved loop of the NAD binding domain. Molecular modeling of the wild-type (WT) protein suggests that the p.Arg89 amino acid is involved in the stabilization of the tetramer through its interaction with p.Asn511 residue at a distance of 5 Å in another subunit (Figure S1B). This latter residue is located in a loop connecting the two β sheets of the monomeric oligomerization domain. Thus, the p.Arg89Cys substitution most likely affects the stability of the tetramer. The p.Ala493 residue is located in a small helix between two β sheets involved in the oligomerization domain of the enzyme (Figure S1C). The introduction of a proline at position 493 in the helix is expected to introduce an elbow, leading to an incorrect position of the two β sheets relative to each other and hampering the tetramerization of the enzyme. Using site-directed mutagenesis (QuikChange II Site-Directed Mutagenesis Kit, Agilent), we introduced the c.265C>T (p.Arg89Cys) and c.1477G>C (p.Ala493Pro) A/M mutations into a pCMV6-entry eukaryote expression vector that encodes the full ALDH1A3 open reading frame and is fused to c-Myc (Origen, Rockville, MD, USA). We also generated a construct harboring a mutation that affected the p.Trp180 (c.538T>G; p.Trp180Gly) residue. This residue corresponds to the p.Trp168 amino acid, which is directly involved in the fixation of NAD in the sheep ALDH1 and does not interfere with the oligomerization of the protein. Primers used for mutagenesis are shown in Table S3. We assessed the effect of the ALDH1A3 substitutions on mRNA and protein levels in human embryonic kidney cells (HEK293 cells) transiently cotransfected with WT or mutant ALDH1A3 constructs, and pCGA-GFP (Addgene, Cambridge, MA, USA) to normalize the data. RT-qPCR using primers specific to the c-Myc tag and the GFP normalizer (Table S4) showed no significant difference in expression between WT and mutant ALDH1A3 mRNA (Figure S2). Immunoblot analysis revealed that the c-Myc-tagged ALDH1A3 p.Arg89Cys and p.Ala493Pro mutant protein levels were strongly reduced compared to the WT and p.Trp180Gly mutant proteins, suggesting that the p.Arg89Cys and p.Ala493Pro mutant proteins might be unstable and subject to proteasomal degradation, leading to an absence or low level of high-molecular-weight complexes (Figure 2). Together, our findings suggest that the synthesis of retinoic acid by ALDH1A3 is impaired in the affected individuals (n = 5) of the three families who consistently presented severe bilateral clinical anophthalmia (extreme microphthalmia with no visible ocular structure). In family 1, the A/M index individual (IV1) was born after full-term normal delivery and was in the 2nd centile for weight (2.59 kg), 3rd centile for length (46.5 cm), and 10th centile for head circumference (33.5 cm). She exhibited small optic nerves and a small optic chiasm upon a cerebral MRI at 1 week of age. Autism was diagnosed at the age of 3 years. She has two healthy sisters. Her mother’s last pregnancy before the study was terminated at 23 weeks of gestation after ultrasonography detection of apparent bilateral anophthalmia with normal brain structures (IV4) detected on ultrasonography. Her maternal cousin (IV5) was born at 34 weeks of gestation by Caesarian section and had a birth weight of 2 kg. He had severe bilateral microphthalmia with cysts (a rudimentary globe on the left and a grossly abnormal globe associated with a cyst on the right), moderate pulmonary and supravalvar pulmonary stenosis, and a moderately sized atrial septal defect. His growth progressed along the 2nd–9th centile for weight and length and 0.4th centile for head circumference. At the age of 4 years, he has a possible diagnosis of autism. The proband in family 2 (IV1) has left and extreme right microphthalmia. She had no other health problems and displays normal intelligence. A review of the family’s medical history revealed that a maternal uncle died at the age of 1 month with bilateral clinical anophthalmia, but we were unable to obtain additional clinical details. Finally, the proband in family 3, who had a homozygous c.475+1G>T mutation was born after a full term and normal delivery and had a birth weight of 3.5 kg (II3; family 3). She presented with severe right microphthalmia and severe left microphthalmia with cyst. An MRI showed dysplastic globes, a hypoplastic chiasm and optic nerves, and a normal remainder of the brain. She had no other health problems and displays normal intelligence. In the mouse, Aldh1a3, along with Aldh1a1 and Aldh1a2, contributes to the synthesis of retinoic acid, which functions as ligand for nuclear receptors that directly regulate gene expression crucial for embryonic eye development.16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 17Fuhrmann S. Eye morphogenesis and patterning of the optic vesicle.Curr. Top. Dev. Biol. 2010; 93: 61-84Crossref PubMed Scopus (249) Google Scholar Aldh1a1, Aldh1a2, and Aldh1a3 are expressed with unique, nonoverlapping, spatiotemporal patterns in embryonic eyes, leading to tissue- and time-restricted retinoic acid synthesis during development.16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 17Fuhrmann S. Eye morphogenesis and patterning of the optic vesicle.Curr. Top. Dev. Biol. 2010; 93: 61-84Crossref PubMed Scopus (249) Google Scholar ALDH1A3 is a key enzyme in the formation of a retinoic acid gradient along the dorso-ventral axis during early eye development. It is required for the complete invagination of the ventral optic cup and closure of the choroid fissure.15Cvekl A. Wang W.L. Retinoic acid signaling in mammalian eye development.Exp. Eye Res. 2009; 89: 280-291Crossref PubMed Scopus (122) Google Scholar, 16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 17Fuhrmann S. Eye morphogenesis and patterning of the optic vesicle.Curr. Top. Dev. Biol. 2010; 93: 61-84Crossref PubMed Scopus (249) Google Scholar, 21Dupé V. Matt N. Garnier J.M. Chambon P. Mark M. Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.Proc. Natl. Acad. Sci. USA. 2003; 100: 14036-14041Crossref PubMed Scopus (246) Google Scholar, 22Molotkov A. Molotkova N. Duester G. Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning.Development. 2006; 133: 1901-1910Crossref PubMed Scopus (162) Google Scholar It also contributes to correct axonal projections of retinal cells into the brain.21Dupé V. Matt N. Garnier J.M. Chambon P. Mark M. Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.Proc. Natl. Acad. Sci. USA. 2003; 100: 14036-14041Crossref PubMed Scopus (246) Google Scholar, 22Molotkov A. Molotkova N. Duester G. Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning.Development. 2006; 133: 1901-1910Crossref PubMed Scopus (162) Google Scholar Interestingly, the phenotype of A/M individuals with ALDH1A3 mutations is consistent with abnormal closures of the choroid fissure and abnormal optic nerve development. Indeed, evidence of cysts in at least two individuals suggests that globe induction—and probably invagination—is present, whereas closure of the choroid fissure may be lacking. In addition, available MRIs showed hypoplastic optic nerves (n = 2). In addition to being a key player in the developing sensory neuroepithelia of the eye, in the mouse, Aldh1a3 plays a role in the development of the nose and ear and in discrete sites within the CNS.16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 17Fuhrmann S. Eye morphogenesis and patterning of the optic vesicle.Curr. Top. Dev. Biol. 2010; 93: 61-84Crossref PubMed Scopus (249) Google Scholar However, knockout of Aldh1a3 causes malformations restricted to ocular and nasal regions.21Dupé V. Matt N. Garnier J.M. Chambon P. Mark M. Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.Proc. Natl. Acad. Sci. USA. 2003; 100: 14036-14041Crossref PubMed Scopus (246) Google Scholar, 22Molotkov A. Molotkova N. Duester G. Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning.Development. 2006; 133: 1901-1910Crossref PubMed Scopus (162) Google Scholar Aldh1a3−/− mutant embryos begin the process of optic cup formation, but they exhibit ventral retina shortening associated with lens rotation and persistence of primary vitreous.16Duester G. Keeping an eye on retinoic acid signaling during eye development.Chem. Biol. Interact. 2009; 178: 178-181Crossref PubMed Scopus (60) Google Scholar, 21Dupé V. Matt N. Garnier J.M. Chambon P. Mark M. Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.Proc. Natl. Acad. Sci. USA. 2003; 100: 14036-14041Crossref PubMed Scopus (246) Google Scholar In addition, the knockout causes choanal atresia, which is responsible for respiratory distress and the death of Aldh1a3−/− mutants at birth.21Dupé V. Matt N. Garnier J.M. Chambon P. Mark M. Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.Proc. Natl. Acad. Sci. USA. 2003; 100: 14036-14041Crossref PubMed Scopus (246) Google Scholar Individuals homozygous for ALDH1A3 mutations had ocular malformations but no nasal defects. Unlike the Aldh1a3 knockout mouse, the affected individuals of the three families harbor mutations expected to result in the production of mutant proteins. We cannot exclude the possibility that the complete loss of function of both ALDH1A3 alleles is lethal in humans. Two out of the four living affected individuals had autism (IV1 and IV5; family 1). The available cerebral MRI of individual IV1 revealed normal cerebellar and cerebral features. Autism and intellectual disability are not infrequent features in individuals affected with A/M.6Morrison D. FitzPatrick D. Hanson I. Williamson K. van Heyningen V. Fleck B. Jones I. Chalmers J. Campbell H. National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology.J. Med. Genet. 2002; 39: 16-22Crossref PubMed Scopus (188) Google Scholar However, given that two A/M individuals had normal intelligence, autism may be unrelated to altered ALDH1A3 function in the CNS. Similarly, it is difficult to decide whether the cardiac anomalies noted in an individual (IV5, family 1) are caused by ALDH1A3 mutations. Nevertheless, it is worth remembering that extraocular anomalies are not uncommon in A/M and that environmental or epigenetic factors have been proposed to explain that some genes are involved in variable phenotypes.12Bakrania P. Robinson D.O. Bunyan D.J. Salt A. Martin A. Crolla J.A. Wyatt A. Fielder A. Ainsworth J. Moore A. et al.SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.Br. J. Ophthalmol. 2007; 91: 1471-1476Crossref PubMed Scopus (88) Google Scholar Additional studies will hopefully allow a more accurate clinical definition of A/M caused by ALDH1A3 mutations. In summary, we report that mutations in ALDH1A3 cause bilateral severe microphthalmia, possibly in association with heart anomalies and autism. Interestingly, the role of retinoic acid synthesis from vitamin A in eye development is well established. Yet, the deciphering of the genetic causes underlying A/M in humans has resulted in the identification of a number of master control genes for the growth and development of eyes, downstream of retinoic acid signaling. The previous example of a direct link between vitamin A deficiency and severe hereditary developmental eye defect in humans is STRA6 [MIM 610745], the gene that encodes the membrane receptor for retinol-binding protein, which mediates cellular uptake of vitamin A,23Kawaguchi R. Yu J. Honda J. Hu J. Whitelegge J. Ping P. Wiita P. Bok D. Sun H. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A.Science. 2007; 315: 820-825Crossref PubMed Scopus (614) Google Scholar and mutations in this gene can cause nonsyndromic and syndromic A/M.8Chassaing N. Golzio C. Odent S. Lequeux L. Vigouroux A. Martinovic-Bouriel J. Tiziano F.D. Masini L. Piro F. Maragliano G. et al.Phenotypic spectrum of STRA6 mutations: from Matthew-Wood syndrome to non-lethal anophthalmia.Hum. Mutat. 2009; 30: E673-E681Crossref PubMed Scopus (76) Google Scholar, 9Chassaing N. Ragge N. Kariminejad A. Buffet A. Ghaderi-Sohi S. Martinovic J. Calvas P. Mutation analysis of the STRA6 gene in isolated and non-isolated anophthalmia/microphthalmia.Clin. Genet. 2012; 9999PubMed Google Scholar Our data provide evidence of a direct link between retinoic acid synthesis dysfunction and eye anomalies in humans. Finally, considering that eye defects in mouse aldh1a mutants can be rescued by maternal dietary retinoic acid supplementation,22Molotkov A. Molotkova N. Duester G. Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning.Development. 2006; 133: 1901-1910Crossref PubMed Scopus (162) Google Scholar this raises the possibility of using this strategy to prevent A/M in conceptus that harbor ALDH1A3 mutations. We are grateful to the families for their participation in the study. We thank A. Martin and L. Harrison for research co-ordination, A. Salt and R. Collin (Moorfields Eye Hospital, London) for clinical support, and D. Robinson (Wessex Regional Genetics Laboratory, Salisbury), N. Graham (Southampton University Hospitals Trust, Southampton), E. Leclerc and B. Leloire (CRB-CHU Biobanque de Picardie, Amiens), and Soraya Sin (Laboratoire d’Oncogénétique, Hôpital René Huguenin-Institut Curie, St Cloud) for technical assistance. This work was supported by grants from Retina France, the Clinical Research Hospital Program of the French Ministry of Health (PHRC 09 109 01), the Academy of Medical Sciences/Health Foundation (NR), VICTA (Visually Impaired Children Taking Action), MACS (Microphthalmia and Anophthalmia Children’s Society), and the Hampshire and Isle of Wight Comprehensive Local Research Network. Download .pdf (.18 MB) Help with pdf files Document S1. Supplemental Experimental Procedures, Figures S1 and S2, and Tables S1–S4 The URLs for data presented herein are as follows:Plateforme Bioinformatique Paris Descartes (BIPD), http://mendel.necker.fr/polyweb/index.htmlAlamut Interpretation Software 2.0, http://alamut.interactive-biosoftware.comExome Variant Server, http://evs.gs.washington.edu/EVSGenome Browser, http://genome.ucsc.eduOnline Mendelian Inheritance in Man (OMIM), http://www.omim.orgSwiss-PdbViewer 3.7, http://www.expasy.org/spdbvdbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP1000 Genomes, http://www.1000genomes.org" @default.
• W2001231501 created "2016-06-24" @default.
• W2001231501 creator A5000393507 @default.
• W2001231501 creator A5006271840 @default.
• W2001231501 creator A5014897085 @default.
• W2001231501 creator A5027512600 @default.
• W2001231501 creator A5028326580 @default.
• W2001231501 creator A5029002217 @default.
• W2001231501 creator A5029343002 @default.
• W2001231501 creator A5038875954 @default.
• W2001231501 creator A5053729675 @default.
• W2001231501 creator A5056744774 @default.
• W2001231501 creator A5057248304 @default.
• W2001231501 creator A5061294621 @default.
• W2001231501 creator A5061852866 @default.
• W2001231501 creator A5062101508 @default.
• W2001231501 creator A5064608643 @default.
• W2001231501 creator A5067089840 @default.
• W2001231501 creator A5068947363 @default.
• W2001231501 creator A5077833232 @default.
• W2001231501 creator A5078964808 @default.
• W2001231501 creator A5085014616 @default.
• W2001231501 creator A5090418762 @default.
• W2001231501 date "2013-02-01" @default.
• W2001231501 modified "2023-10-17" @default.
• W2001231501 title "ALDH1A3 Mutations Cause Recessive Anophthalmia and Microphthalmia" @default.
• W2001231501 cites W1509287381 @default.
• W2001231501 cites W1979451137 @default.
• W2001231501 cites W1987631153 @default.
• W2001231501 cites W1997844919 @default.
• W2001231501 cites W1999132350 @default.
• W2001231501 cites W2003589493 @default.
• W2001231501 cites W2013840838 @default.
• W2001231501 cites W2017841489 @default.
• W2001231501 cites W2027554821 @default.
• W2001231501 cites W2038035869 @default.
• W2001231501 cites W2038639188 @default.
• W2001231501 cites W2057386276 @default.
• W2001231501 cites W2057877618 @default.
• W2001231501 cites W2089125385 @default.
• W2001231501 cites W2105691494 @default.
• W2001231501 cites W2107333442 @default.
• W2001231501 cites W2118200955 @default.
• W2001231501 cites W2148684568 @default.
• W2001231501 cites W2149940976 @default.
• W2001231501 cites W2152301430 @default.
• W2001231501 cites W2161095017 @default.
• W2001231501 cites W2164344960 @default.
• W2001231501 doi "https://doi.org/10.1016/j.ajhg.2012.12.003" @default.
• W2001231501 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3567280" @default.
• W2001231501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23312594" @default.
• W2001231501 hasPublicationYear "2013" @default.
• W2001231501 type Work @default.
• W2001231501 sameAs 2001231501 @default.
• W2001231501 citedByCount "88" @default.
• W2001231501 countsByYear W20012315012013 @default.
• W2001231501 countsByYear W20012315012014 @default.
• W2001231501 countsByYear W20012315012015 @default.
• W2001231501 countsByYear W20012315012016 @default.
• W2001231501 countsByYear W20012315012017 @default.
• W2001231501 countsByYear W20012315012018 @default.
• W2001231501 countsByYear W20012315012019 @default.
• W2001231501 countsByYear W20012315012020 @default.
• W2001231501 countsByYear W20012315012021 @default.
• W2001231501 countsByYear W20012315012022 @default.
• W2001231501 countsByYear W20012315012023 @default.
• W2001231501 crossrefType "journal-article" @default.
• W2001231501 hasAuthorship W2001231501A5000393507 @default.
• W2001231501 hasAuthorship W2001231501A5006271840 @default.
• W2001231501 hasAuthorship W2001231501A5014897085 @default.
• W2001231501 hasAuthorship W2001231501A5027512600 @default.
• W2001231501 hasAuthorship W2001231501A5028326580 @default.
• W2001231501 hasAuthorship W2001231501A5029002217 @default.
• W2001231501 hasAuthorship W2001231501A5029343002 @default.
• W2001231501 hasAuthorship W2001231501A5038875954 @default.
• W2001231501 hasAuthorship W2001231501A5053729675 @default.
• W2001231501 hasAuthorship W2001231501A5056744774 @default.
• W2001231501 hasAuthorship W2001231501A5057248304 @default.
• W2001231501 hasAuthorship W2001231501A5061294621 @default.
• W2001231501 hasAuthorship W2001231501A5061852866 @default.
• W2001231501 hasAuthorship W2001231501A5062101508 @default.
• W2001231501 hasAuthorship W2001231501A5064608643 @default.
• W2001231501 hasAuthorship W2001231501A5067089840 @default.
• W2001231501 hasAuthorship W2001231501A5068947363 @default.
• W2001231501 hasAuthorship W2001231501A5077833232 @default.
• W2001231501 hasAuthorship W2001231501A5078964808 @default.
• W2001231501 hasAuthorship W2001231501A5085014616 @default.
• W2001231501 hasAuthorship W2001231501A5090418762 @default.
• W2001231501 hasBestOaLocation W20012315011 @default.
• W2001231501 hasConcept C104317684 @default.
• W2001231501 hasConcept C2777424935 @default.
• W2001231501 hasConcept C2778085061 @default.
• W2001231501 hasConcept C47042493 @default.
• W2001231501 hasConcept C54355233 @default.
• W2001231501 hasConcept C71924100 @default.
• W2001231501 hasConcept C86803240 @default.
• W2001231501 hasConceptScore W2001231501C104317684 @default.
• W2001231501 hasConceptScore W2001231501C2777424935 @default.

• next